vs

Side-by-side financial comparison of Alset Inc. (AEI) and Instil Bio, Inc. (TIL). Click either name above to swap in a different company.

Instil Bio, Inc. is the larger business by last-quarter revenue ($2.2M vs $1.3M, roughly 1.7× Alset Inc.). On growth, Instil Bio, Inc. posted the faster year-over-year revenue change (-19.2% vs -85.4%).

Alset Global GmbH is an Austrian technology and engineering company based in Graz that specialises in hydrogen-based clean mobility products. Alset Global is known for developing a Hybrid Hydrogen internal combustion engine that can run on either pure petrol, pure hydrogen or a combination of both. This technology offers a sustainable and clean alternative to petrol-based internal combustion engines. The technology has been developed to create an alternative technology to meet new emission ta...

Instil Bio Inc. is a clinical-stage biotechnology company focused on developing innovative tumor-infiltrating lymphocyte (TIL) therapies for patients with difficult-to-treat advanced solid tumors. It operates in the immuno-oncology segment, serving patient populations that show limited response to existing standard cancer treatment options.

AEI vs TIL — Head-to-Head

Bigger by revenue
TIL
TIL
1.7× larger
TIL
$2.2M
$1.3M
AEI
Growing faster (revenue YoY)
TIL
TIL
+66.2% gap
TIL
-19.2%
-85.4%
AEI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AEI
AEI
TIL
TIL
Revenue
$1.3M
$2.2M
Net Profit
$-8.2M
Gross Margin
35.2%
Operating Margin
-426.3%
Net Margin
-365.3%
Revenue YoY
-85.4%
-19.2%
Net Profit YoY
-1491.5%
31.1%
EPS (diluted)
$-1.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AEI
AEI
TIL
TIL
Q4 25
$1.3M
$2.2M
Q3 25
$998.8K
$2.2M
Q2 25
$1.1M
$2.2M
Q1 25
$1.1M
$2.2M
Q4 24
$8.9M
$2.8M
Q3 24
$5.0M
$1.5M
Q2 24
$1.1M
$0
Q1 24
$6.1M
$0
Net Profit
AEI
AEI
TIL
TIL
Q4 25
$-8.2M
Q3 25
$1.5M
$-13.6M
Q2 25
$-8.2M
$-21.4M
Q1 25
$-8.3M
$-28.2M
Q4 24
$2.3M
$-11.9M
Q3 24
$1.7M
$-23.0M
Q2 24
$-1.2M
$-14.9M
Q1 24
$-6.8M
$-24.3M
Gross Margin
AEI
AEI
TIL
TIL
Q4 25
35.2%
Q3 25
24.3%
Q2 25
23.3%
Q1 25
27.2%
Q4 24
51.4%
Q3 24
40.5%
Q2 24
26.4%
Q1 24
23.5%
Operating Margin
AEI
AEI
TIL
TIL
Q4 25
-426.3%
Q3 25
-258.2%
-670.0%
Q2 25
-250.7%
-1045.5%
Q1 25
-368.1%
-1363.2%
Q4 24
21.5%
-426.1%
Q3 24
-19.4%
-1582.8%
Q2 24
-249.3%
Q1 24
-37.2%
Net Margin
AEI
AEI
TIL
TIL
Q4 25
-365.3%
Q3 25
151.4%
-606.0%
Q2 25
-748.1%
-954.2%
Q1 25
-780.1%
-1257.8%
Q4 24
26.0%
-428.8%
Q3 24
34.6%
-1541.9%
Q2 24
-109.9%
Q1 24
-111.2%
EPS (diluted)
AEI
AEI
TIL
TIL
Q4 25
$-1.13
Q3 25
$0.05
$-2.01
Q2 25
$-0.71
$-3.24
Q1 25
$-0.78
$-4.32
Q4 24
$0.24
$-1.82
Q3 24
$0.19
$-3.54
Q2 24
$-0.13
$-2.29
Q1 24
$-0.73
$-3.74

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AEI
AEI
TIL
TIL
Cash + ST InvestmentsLiquidity on hand
$25.2M
$6.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$121.1M
$113.9M
Total Assets
$136.6M
$203.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AEI
AEI
TIL
TIL
Q4 25
$25.2M
$6.6M
Q3 25
$25.5M
$5.8M
Q2 25
$25.6M
$7.7M
Q1 25
$25.2M
$15.4M
Q4 24
$27.2M
$8.8M
Q3 24
$16.7M
$6.7M
Q2 24
$18.9M
$6.8M
Q1 24
$23.7M
$5.5M
Total Debt
AEI
AEI
TIL
TIL
Q4 25
Q3 25
Q2 25
Q1 25
$116.5K
Q4 24
$123.1K
Q3 24
$137.9K
Q2 24
$137.8K
Q1 24
$145.8K
Stockholders' Equity
AEI
AEI
TIL
TIL
Q4 25
$121.1M
$113.9M
Q3 25
$155.7M
$120.4M
Q2 25
$72.8M
$131.7M
Q1 25
$76.4M
$144.9M
Q4 24
$81.3M
$169.4M
Q3 24
$84.2M
$176.3M
Q2 24
$79.4M
$195.0M
Q1 24
$81.7M
$205.8M
Total Assets
AEI
AEI
TIL
TIL
Q4 25
$136.6M
$203.5M
Q3 25
$169.1M
$211.8M
Q2 25
$86.0M
$231.0M
Q1 25
$90.5M
$237.4M
Q4 24
$96.8M
$263.6M
Q3 24
$98.8M
$272.6M
Q2 24
$93.5M
$294.3M
Q1 24
$96.7M
$306.3M
Debt / Equity
AEI
AEI
TIL
TIL
Q4 25
Q3 25
Q2 25
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AEI
AEI
TIL
TIL
Operating Cash FlowLast quarter
$-5.9M
$-7.1M
Free Cash FlowOCF − Capex
$-6.1M
FCF MarginFCF / Revenue
-467.7%
Capex IntensityCapex / Revenue
13.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-11.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AEI
AEI
TIL
TIL
Q4 25
$-5.9M
$-7.1M
Q3 25
$883.4K
$-10.6M
Q2 25
$-2.6M
$-14.8M
Q1 25
$-3.8M
$-4.2M
Q4 24
$5.2M
$-10.6M
Q3 24
$-2.9M
$-20.1M
Q2 24
$-4.4M
$-10.6M
Q1 24
$-1.5M
$-14.4M
Free Cash Flow
AEI
AEI
TIL
TIL
Q4 25
$-6.1M
Q3 25
$822.4K
Q2 25
$-2.7M
Q1 25
$-3.8M
Q4 24
$5.1M
Q3 24
$-2.9M
Q2 24
$-4.4M
Q1 24
$-1.5M
FCF Margin
AEI
AEI
TIL
TIL
Q4 25
-467.7%
Q3 25
82.3%
Q2 25
-245.9%
Q1 25
-357.3%
Q4 24
56.5%
Q3 24
-58.2%
Q2 24
-392.3%
Q1 24
-24.8%
Capex Intensity
AEI
AEI
TIL
TIL
Q4 25
13.4%
Q3 25
6.1%
Q2 25
7.6%
Q1 25
5.7%
Q4 24
1.1%
0.0%
Q3 24
0.6%
0.0%
Q2 24
3.0%
Q1 24
0.0%
Cash Conversion
AEI
AEI
TIL
TIL
Q4 25
Q3 25
0.58×
Q2 25
Q1 25
Q4 24
2.22×
Q3 24
-1.66×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons